View More Recent Stories
-
Leerink Partners Assumes Trevi Therapeutics (TRVI) at Outperform 'based on the potential of lead asset Haduvio'
-
Raymond James Starts Trevi Therapeutics (TRVI) at Outperform
-
H.C. Wainwright Starts Trevi Therapeutics (TRVI) at Buy
-
EF Hutton Starts Trevi Therapeutics (TRVI) at Buy
-
Trevi Therapeutics (TRVI) Misses Q2 EPS by 1c

